SGLT2 inhibitors and cardiovascular outcomes in patients with multiple myeloma and concomitant type 2 diabetes mellitus.

Authors

Jia Yi Tan
Aravinthan Vignarajah
Yong Hao Yeo
Kok Hoe Chan
Mohammad Muhsin Chisti, Corewell Health East
Talal Hilal

Document Type

Article

Publication Date

7-22-2025

Publication Title

Leukemia & lymphoma

First Page

1

Last Page

4

Recommended Citation

Tan JY, Vignarajah A, Yeo YH, Chan KH, Chisti MM, Hilal T. SGLT2 inhibitors and cardiovascular outcomes in patients with multiple myeloma and concomitant type 2 diabetes mellitus. Leuk Lymphoma. 2025 Jul 22:1-4. doi: 10.1080/10428194.2025.2536681. Epub ahead of print. PMID: 40694617.

DOI

10.1080/10428194.2025.2536681

ISSN

1029-2403

PubMed ID

40694617